BRAF/MEK inhibitors selectively prime melanoma for Mcl-1 dependence and sensitize to Mcl-1 inhibition

Kump, KJ; Miao, L; Ansari, N; Lombard, DB; Nikolovska-Coleska, Z

CANCER RESEARCH, 2019; 79 (13):